Real world switching therapies analysis in a retro-prospective cohort of patients with multiple sclerosis

被引：0
|
作者：
Mallucci, G. [1 ]
Zito, A. [1 ]
Bergamaschi, R. [1 ]
机构：
[1] IRCCS Mondino, Pavia, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P846
引用
收藏
页码：696 / 697
页数：2
相关论文
共 50 条
  • [31] Results of treatment with alemtuzumab in a Spanish cohort of patients with multiple sclerosis in the real world: The RealMS study
    Eichau, Sara
    Ruiz, Rocio Lopez
    de Arcos, Maria Ruiz
    Ruiz-Pena, Juan Luis
    Navarro, Guillermo
    Calleja, Miguel Angel
    Moreno-Amador, Jose Luis
    Garcia-Soto, Julio Dotor
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [32] Belantamab mafodotin in patients with relapsed/refractory multiple myeloma who are triple-refractory: a retro-prospective Italian observational study
    Offidani, Massimo
    More, Sonia
    Cavo, Michele
    Derudas, Daniele
    Di Raimondo, Francesco
    Cuneo, Antonio
    Baldini, Luca
    Della Pepa, Roberta
    Musso, Maurizio
    Boccadoro, Mario
    Musto, Pellegrino
    Belotti, Angelo
    Fioritoni, Francesca
    Di Renzo, Nicola
    Mele, Anna
    Gamberi, Barbara
    De Paoli, Lorenzo
    Zambello, Renato
    Grammatico, Sara
    Brociner, Marco
    Fazio, Francesca
    Petrucci, Maria-Teresa
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S205 - S205
  • [33] Real-world persistence of multiple sclerosis disease-modifying therapies
    Tallantyre, Emma C.
    Dobson, Ruth
    Froud, Joseph L. J.
    St John, Frederika A.
    Anderson, Valerie M.
    Arun, Tarunya
    Buckley, Lauren
    Evangelou, Nikos
    Ford, Helen L.
    Galea, Ian
    George, Sumi
    Gray, Orla M.
    Hibbert, Aimee M.
    Hu, Mo
    Hughes, Stella E.
    Ingram, Gillian
    Kalra, Seema
    Lim, Chia-Hui E.
    Mathews, Joela T. M.
    McDonnell, Gavin V.
    Mescall, Naomi
    Norris, Sam
    Ramsay, Stephen J.
    Rice, Claire M.
    Russell, Melanie J.
    Shawe-Taylor, Marianne J.
    Williams, Thomas E.
    Harding, Katharine E.
    Robertson, Neil P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (07)
  • [34] Real-world switching patterns among US generic glatiramer acetate multiple sclerosis patients
    Alexander, Jessica
    Kasturi, Jyotsna
    Melamed-Gal, Sigal
    Ariely, Rinat
    Vardi, Michaela
    Su, Zhaohui
    Brecht, Thomas
    Bryant, Allison
    NEUROLOGY, 2019, 92 (15)
  • [35] Switching disease-modifying therapies in multiple sclerosis patients: A study on 110 patients
    Morra, V. Brescia
    Coppola, G.
    Vacca, G.
    Longobardi, M.
    Ascione, S.
    Schiavone, V.
    Pagano, A.
    Bonavita, V.
    Orefice, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 263 - 264
  • [36] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [37] A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
    Sandgren, Sofia
    Novakova, Lenka
    Nordin, Anna
    Axelsson, Markus
    Malmestrom, Clas
    Zetterberg, Henrik
    Lycke, Jan
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [38] Real-World Effectiveness and Safety of Fingolimod in Patients With Relapsing Remitting Multiple Sclerosis: A Prospective Analysis in Buenos Aires, Argentina
    Patrucco, Liliana
    Cristiano, Edgardo
    Sanchez, Francisco
    Miguez, Jimena
    Rojas, Juan Ignacio
    CLINICAL NEUROPHARMACOLOGY, 2019, 42 (05) : 163 - 166
  • [39] Characteristics of multiple sclerosis patients treated with highly effective DMTs in a large real-world cohort
    Hersh, C.
    Honomichl, R.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 858 - 858
  • [40] REAL WORLD EVIDENCE TO SUPPORT THE CLINICAL EFFECTIVENESS OF MULTIPLE SCLEROSIS THERAPIES: A US PERSPECTIVE
    Sadosky, A.
    Ambegaonkar, A. J.
    VALUE IN HEALTH, 2021, 24 : S158 - S158
12345